Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine

J Microencapsul. 1994 May-Jun;11(3):249-60. doi: 10.3109/02652049409040454.

Abstract

The preparation and characterization of gelatin microspheres (GMs) containing the antitumour aromatic tetra-amidine TAPP-Br and its release characteristics from microspheres are described. Spherical gelatin microspheres, showing a high percentage of drug encapsulation (over 95 per cent) and an average diameter of 16 microns were obtained by a coacervation method. In addition, the effects of various reaction parameters on the production and chemical hardening of GMs have been investigated. In order to compare the TAPP-Br release profiles from GMs prepared with different procedures, in vitro studies were carried out. The biological effect of TAPP-Br released from gelatin microspheres was determined on 'in vitro' cultured tumour cell lines, showing that, after encapsulation, TAPP-Br still retains antiproliferative activity comparable with that exhibited by the free drug. Taken together, the results obtained suggest that gelatin-based microspheres offer excellent potential as carriers for the controlled release of polyamidines in anticancer chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacokinetics
  • Benzamidines / administration & dosage*
  • Benzamidines / chemistry*
  • Benzamidines / pharmacokinetics
  • Chemistry, Pharmaceutical
  • Cross-Linking Reagents / chemistry
  • Drug Stability
  • Gelatin / chemistry*
  • Glutaral / chemistry
  • Humans
  • Leukemia / metabolism
  • Microspheres
  • Solubility

Substances

  • Antineoplastic Agents
  • Benzamidines
  • Cross-Linking Reagents
  • Gelatin
  • 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide
  • Glutaral